PT-141
Also known as: Bremelanotide, Vyleesi
The Desire Peptide
FDA-approved for female sexual dysfunction. Works on the brain (not blood flow) to increase desire.
How It Works
Simple Explanation
Activates melanocortin receptors in the brain to increase sexual desire and arousal.
Technical Details
MC4R agonist affecting the central nervous system pathways involved in sexual desire, distinct from PDE5 inhibitors.
Pharmacokinetics & Storage
Half-Life
~2.5 hours
Duration in circulation
Storage Requirements
Reconstitute with bacteriostatic water. Protect from light. FDA-approved Vyleesi autoinjectors have specific storage instructions.
Research Timeline: What Studies Have Observed
Based on clinical trial data and published research. Individual responses may vary significantly.
Acute (45-60 min)
Research shows sexual desire and arousal increase typically peaks 45 minutes to 2 hours after administration.
Duration
Studies indicate effects last 6-12 hours on average. Timing dose 45+ minutes before anticipated activity is optimal.
With repeated use
Research suggests effects remain consistent with as-needed use. Some users report cumulative improvement in baseline desire over weeks.
Long-term
No tolerance development observed in clinical trials with as-needed dosing. FDA approves up to 8 doses monthly.
Benefits
- Increased sexual desire
- Works on brain (not just blood flow)
- Effective for both genders
- Works when Viagra/Cialis don't
- FDA approved option
Potential Side Effects
Nausea
Common (40%)
Flushing
Common
Headache
Common
Skin darkening
Occasional with repeated use
Known Interactions
Based on clinical research and pharmacological studies. Always consult a healthcare provider about potential interactions.
Antihypertensives
cautionPT-141 can raise blood pressure transiently. Use caution with blood pressure medications and monitor accordingly.
Alpha blockers
avoidRisk of hypotension. Research advises against combining PT-141 with alpha-blocking agents.
Melanotan I/II
cautionBoth are melanocortin agonists. Combining may increase side effects including nausea and skin darkening.
Naltrexone
monitorSome theoretical interaction potential. Both affect reward pathways. Limited data available.
Research Highlights
Male Sexual Dysfunction Study (2023)
Demonstrated efficacy for erectile dysfunction with central mechanism of action
View StudyFrequently Asked Questions
How is PT-141 different from Viagra/Cialis?
Does PT-141 work for men?
Why does PT-141 cause nausea?
Can PT-141 darken my skin?
Who Is It For
- Female hypoactive sexual desire disorder
- Male sexual dysfunction
- Those who don't respond to PDE5 inhibitors
Who Should Avoid
- Uncontrolled hypertension
- Cardiovascular disease
- Those on vasopressors
How It Compares
Research-based comparisons with similar peptides. Individual responses and circumstances should guide decisions.
Kisspeptin works on hormone regulation at the hypothalamic level. PT-141 is more direct for acute desire/arousal. Kisspeptin may be better for hormonal optimization.
Melanotan II also increases libido (plus tanning) but isn't FDA-approved and has more side effects. PT-141 is FDA-approved and more targeted for sexual function.
Research Dosing Protocols
Common Research Protocol
1.75mg subcutaneous, 45 min before activity
Administration Frequency (per studies)
As needed, max 8 doses/month
Delivery Methods
👃 This peptide is also available in nasal spray form from select suppliers.
Available Forms
- • Subcutaneous injection
- • Nasal spray (research)
⚠️ Not Medical Advice: Dosing information is compiled from published research and clinical studies for educational purposes only. This is not a recommendation. All peptide research should be conducted by qualified professionals in controlled research environments. Consult a healthcare provider before considering any protocol.
Cost Context
FDA-approved Vyleesi: ~$1,000 per package of 4 autoinjectors without insurance. Research-grade PT-141: $40-80 per 10mg vial. Significant cost difference between pharmaceutical and research forms.
Prices vary by region, source, and insurance coverage. This is general context only.
⚠️ Important Disclaimer
This information is for educational purposes only and is not medical advice. Many peptides discussed are research compounds not approved for human use by the FDA. Always consult with a qualified healthcare provider before starting any peptide protocol. PepGains does not sell peptides and is not responsible for how this information is used. All timeline and efficacy information is based on published research and clinical trials - individual results may vary significantly.